Published in Infect Immun on January 01, 2006
Retracted A genetically enhanced anaerobic bacterium for oncopathic therapy of pancreatic cancer. J Natl Cancer Inst (2008) 1.84
Cutting edge: resistance to Bacillus anthracis infection mediated by a lethal toxin sensitive allele of Nalp1b/Nlrp1b. J Immunol (2009) 1.63
Toxin-deficient mutants of Bacillus anthracis are lethal in a murine model for pulmonary anthrax. Infect Immun (2006) 1.45
Inflammasome sensor Nlrp1b-dependent resistance to anthrax is mediated by caspase-1, IL-1 signaling and neutrophil recruitment. PLoS Pathog (2010) 1.39
Human monoclonal antibody AVP-21D9 to protective antigen reduces dissemination of the Bacillus anthracis Ames strain from the lungs in a rabbit model. Infect Immun (2007) 1.37
Poly-gamma-glutamate capsule-degrading enzyme treatment enhances phagocytosis and killing of encapsulated Bacillus anthracis. Antimicrob Agents Chemother (2006) 1.34
Detection of Bacillus anthracis spore germination in vivo by bioluminescence imaging. Infect Immun (2008) 1.19
Bacillus anthracis spores of the bclA mutant exhibit increased adherence to epithelial cells, fibroblasts, and endothelial cells but not to macrophages. Infect Immun (2007) 1.18
Role of anthrax toxins in dissemination, disease progression, and induction of protective adaptive immunity in the mouse aerosol challenge model. Infect Immun (2008) 1.14
Updating perspectives on the initiation of Bacillus anthracis growth and dissemination through its host. Infect Immun (2012) 1.10
Differential role of the interleukin-17 axis and neutrophils in resolution of inhalational anthrax. Infect Immun (2011) 1.07
Bacillus anthracis peptidoglycan stimulates an inflammatory response in monocytes through the p38 mitogen-activated protein kinase pathway. PLoS One (2008) 1.07
Targeted deletion of tumor suppressor PTEN augments neutrophil function and enhances host defense in neutropenia-associated pneumonia. Blood (2009) 1.06
Discriminating virulence mechanisms among Bacillus anthracis strains by using a murine subcutaneous infection model. Infect Immun (2008) 1.06
Anthrax lethal toxin impairs IL-8 expression in epithelial cells through inhibition of histone H3 modification. PLoS Pathog (2009) 1.04
Fully virulent Bacillus anthracis does not require the immunodominant protein BclA for pathogenesis. Infect Immun (2006) 1.04
Four superoxide dismutases contribute to Bacillus anthracis virulence and provide spores with redundant protection from oxidative stress. Infect Immun (2008) 1.03
Treatment of experimental anthrax with recombinant capsule depolymerase. Antimicrob Agents Chemother (2007) 1.02
Humanized theta-defensins (retrocyclins) enhance macrophage performance and protect mice from experimental anthrax infections. Antimicrob Agents Chemother (2011) 0.99
In vivo demonstration and quantification of intracellular Bacillus anthracis in lung epithelial cells. Infect Immun (2008) 0.99
Cathelicidin administration protects mice from Bacillus anthracis spore challenge. J Immunol (2008) 0.95
Role of purine biosynthesis in Bacillus anthracis pathogenesis and virulence. Infect Immun (2010) 0.95
Experimental cutaneous Bacillus anthracis infections in hairless HRS/J mice. Int J Exp Pathol (2007) 0.94
Anthrax toxin uptake by primary immune cells as determined with a lethal factor-beta-lactamase fusion protein. PLoS One (2009) 0.93
Inhalational anthrax (Ames aerosol) in naïve and vaccinated New Zealand rabbits: characterizing the spread of bacteria from lung deposition to bacteremia. Front Cell Infect Microbiol (2012) 0.92
Recombinant Bacillus anthracis spore proteins enhance protection of mice primed with suboptimal amounts of protective antigen. Vaccine (2008) 0.91
IL-12 p80-dependent macrophage recruitment primes the host for increased survival following a lethal respiratory viral infection. Immunology (2008) 0.90
Frequent and seasonally variable sublethal anthrax infections are accompanied by short-lived immunity in an endemic system. J Anim Ecol (2014) 0.90
Resistance of human alveolar macrophages to Bacillus anthracis lethal toxin. J Immunol (2009) 0.90
Immunomodulatory and protective roles of quorum-sensing signaling molecules N-acyl homoserine lactones during infection of mice with Aeromonas hydrophila. Infect Immun (2011) 0.88
Superficial exudates of neutrophils prevent invasion of Bacillus anthracis bacilli into abraded skin of resistant mice. Int J Exp Pathol (2008) 0.88
Bacillus anthracis edema toxin suppresses human macrophage phagocytosis and cytoskeletal remodeling via the protein kinase A and exchange protein activated by cyclic AMP pathways. Infect Immun (2009) 0.88
Bacillus anthracis spore interactions with mammalian cells: relationship between germination state and the outcome of in vitro. BMC Microbiol (2011) 0.88
Efficacy of a vaccine based on protective antigen and killed spores against experimental inhalational anthrax. Infect Immun (2008) 0.86
Bacillus anthracis factors for phagosomal escape. Toxins (Basel) (2012) 0.86
Inhibition of anthrax lethal toxin-induced cytolysis of RAW264.7 cells by celastrol. PLoS One (2008) 0.85
Transcriptional and apoptotic responses of THP-1 cells to challenge with toxigenic, and non-toxigenic Bacillus anthracis. BMC Immunol (2008) 0.85
Cellular and physiological effects of anthrax exotoxin and its relevance to disease. Front Cell Infect Microbiol (2012) 0.84
Debridement increases survival in a mouse model of subcutaneous anthrax. PLoS One (2012) 0.84
Modeling the host response to inhalation anthrax. J Theor Biol (2011) 0.81
New insights into gastrointestinal anthrax infection. Trends Mol Med (2014) 0.81
The International Bacillus anthracis, B. cereus, and B. thuringiensis Conference, "Bacillus-ACT05". J Bacteriol (2006) 0.81
Vaccine protection against Bacillus cereus-mediated respiratory anthrax-like disease in mice. Infect Immun (2013) 0.81
Delayed toxicity associated with soluble anthrax toxin receptor decoy-Ig fusion protein treatment. PLoS One (2012) 0.80
Emergence of anthrax edema toxin as a master manipulator of macrophage and B cell functions. Toxins (Basel) (2010) 0.79
Characterization of a multi-component anthrax vaccine designed to target the initial stages of infection as well as toxaemia. J Med Microbiol (2012) 0.79
Anthrax toxin delivers a one-two punch. Cell Host Microbe (2010) 0.79
What is the relevance of lung epithelial cells during the dissemination of spores in inhalational anthrax? Infect Immun (2009) 0.78
Immunization of mice with formalin-inactivated spores from avirulent Bacillus cereus strains provides significant protection from challenge with Bacillus anthracis Ames. Clin Vaccine Immunol (2012) 0.78
Bacillus anthracis has two independent bottlenecks that are dependent on the portal of entry in an intranasal model of inhalational infection. Infect Immun (2013) 0.78
Anthrax Toxins in Context of Bacillus anthracis Spores and Spore Germination. Toxins (Basel) (2015) 0.77
Crossing of the epithelial barriers by Bacillus anthracis: the Known and the Unknown. Front Microbiol (2015) 0.75
Potential role of autophagy in the bactericidal activity of human PMNs for Bacillus anthracis. Pathog Dis (2015) 0.75
Transient lipopolysaccharide-induced resistance to aerosolized Bacillus anthracis in New Zealand white rabbits. Comp Med (2013) 0.75
Surviving Between Hosts: Sporulation and Transmission. Microbiol Spectr (2016) 0.75
IL-1β processing in mechanical ventilation-induced inflammation is dependent on neutrophil factors rather than caspase-1. Intensive Care Med Exp (2013) 0.75
Tetrazole-Based trans-Translation Inhibitors Kill Bacillus anthracis Spores to Protect Host Cells. Antimicrob Agents Chemother (2017) 0.75
Bacillus anthracis spore movement does not require a carrier cell and is not affected by lethal toxin in human lung models. Microbes Infect (2016) 0.75
Liposome mediated depletion of macrophages: mechanism of action, preparation of liposomes and applications. J Immunol Methods (1994) 13.53
Anthrax. Annu Rev Microbiol (2001) 9.69
Anthrax. N Engl J Med (1999) 8.89
The stability of messenger ribonucleic acid during sporulation in Bacillus subtilis. J Biol Chem (1971) 6.49
The production of cytokines by polymorphonuclear neutrophils. Immunol Today (1995) 4.27
Neutrophils are essential for early anti-Listeria defense in the liver, but not in the spleen or peritoneal cavity, as revealed by a granulocyte-depleting monoclonal antibody. J Exp Med (1994) 4.16
Differences in susceptibility of inbred mice to Bacillus anthracis. Infect Immun (1986) 3.78
Germination of Bacillus anthracis spores within alveolar macrophages. Mol Microbiol (1999) 3.49
Early Bacillus anthracis-macrophage interactions: intracellular survival survival and escape. Cell Microbiol (2000) 3.11
Administration of anti-granulocyte mAb RB6-8C5 impairs the resistance of mice to Listeria monocytogenes infection. J Immunol (1994) 3.02
The structure of spores as revealed by mechanical disruption. J Bacteriol (1953) 2.72
The role of antibodies to Bacillus anthracis and anthrax toxin components in inhibiting the early stages of infection by anthrax spores. Microbiology (2001) 2.55
Effects of anthrax toxin components on human neutrophils. Infect Immun (1985) 2.51
Elimination of mouse splenic macrophages correlates with increased susceptibility to experimental disseminated candidiasis. J Immunol (1994) 2.34
Fate of germinated Bacillus anthracis spores in primary murine macrophages. Mol Microbiol (2001) 2.30
Spore germination. Cell Mol Life Sci (2002) 2.28
Murine model of pulmonary anthrax: kinetics of dissemination, histopathology, and mouse strain susceptibility. Infect Immun (2004) 2.14
Neutrophil-mediated suppression of virus replication after herpes simplex virus type 1 infection of the murine cornea. J Virol (1996) 2.14
Identification and characterization of a germination operon on the virulence plasmid pXO1 of Bacillus anthracis. Mol Microbiol (1999) 2.12
Quantitative pathology of inhalational anthrax I: quantitative microscopic findings. Mod Pathol (2001) 2.10
Early recruitment of neutrophils determines subsequent T1/T2 host responses in a murine model of Legionella pneumophila pneumonia. J Immunol (2001) 2.00
Capsule synthesis by Bacillus anthracis is required for dissemination in murine inhalation anthrax. EMBO J (2004) 1.98
Pathogenesis and genetic control of resistance to the Sterne strain of Bacillus anthracis. Microb Pathog (1988) 1.98
Mouse susceptibility to anthrax lethal toxin is influenced by genetic factors in addition to those controlling macrophage sensitivity. Infect Immun (2004) 1.95
Depletion of alveolar macrophages exerts protective effects in pulmonary tuberculosis in mice. J Immunol (2001) 1.95
The alveolar macrophage: the Trojan horse of Bacillus anthracis. Trends Microbiol (2002) 1.88
Efficacy of D0870 compared with those of itraconazole and amphotericin B in two murine models of invasive aspergillosis. Antimicrob Agents Chemother (1995) 1.86
Cytokine response to infection with Bacillus anthracis spores. Infect Immun (2004) 1.86
Anthrax pathogenesis and host response. Curr Top Microbiol Immunol (1998) 1.83
Anthrax: clinical features, pathogenesis, and potential biological warfare threat. Curr Clin Top Infect Dis (2000) 1.81
Bacteria in the bloodstream are trapped in the liver and killed by immigrating neutrophils. J Immunol (1996) 1.79
Toxins of Bacillus anthracis. Toxicon (2001) 1.74
Macrophage subset repopulation in the spleen: differential kinetics after liposome-mediated elimination. J Leukoc Biol (1989) 1.71
Understanding Bacillus anthracis pathogenesis. Trends Microbiol (1999) 1.70
In-vitro characterisation of the phagocytosis and fate of anthrax spores in macrophages and the effects of anti-PA antibody. J Med Microbiol (2002) 1.60
The critical-orifice liquid impinger as a sampler for bacterial aerosols. Appl Microbiol (1957) 1.59
Resistance to the Sterne strain of B. anthracis: phagocytic cell responses of resistant and susceptible mice. Microb Pathog (1989) 1.56
Macrophage-enhanced germination of Bacillus anthracis endospores requires gerS. Infect Immun (2002) 1.42
Systemic cytokine response in murine anthrax. Cell Microbiol (2004) 1.41
How do neutrophils and pathogens interact? Curr Opin Microbiol (2004) 1.40
The use of a model of in vivo macrophage depletion to study the role of macrophages during infection with Bacillus anthracis spores. Microb Pathog (2004) 1.34
Anthrax lethal toxin paralyzes neutrophil actin-based motility. J Infect Dis (2005) 1.32
Anthrax toxin blocks priming of neutrophils by lipopolysaccharide and by muramyl dipeptide. J Exp Med (1986) 1.21
In vivo activity of amphotericin B lipid complex in immunocompromised mice against fluconazole-resistant or fluconazole-susceptible Candida tropicalis. Antimicrob Agents Chemother (2000) 1.21
Comparative study of pressure- and nutrient-induced germination of Bacillus subtilis spores. Appl Environ Microbiol (2000) 1.21
The interaction between CD8+ cytotoxic T cells and Leishmania-infected macrophages. J Exp Med (1991) 1.18
Complement depletion renders C57BL/6 mice sensitive to the Bacillus anthracis Sterne strain. Infect Immun (2005) 1.17
Construction of a rhamnose mutation in Bacillus anthracis affects adherence to macrophages but not virulence in guinea pigs. Microb Pathog (2005) 1.15
Regulation of chemokine gene expression in human peripheral blood neutrophils phagocytosing microbial pathogens. J Immunol (1998) 1.14
Polymorphonuclear neutrophils are necessary for the recruitment of CD8(+) T cells in the liver in a pregnant mouse model of Chlamydophila abortus (Chlamydia psittaci serotype 1) infection. Infect Immun (2000) 1.14
Anthrax toxin. Crit Rev Microbiol (2001) 1.12
Anthrax edema toxin requires influx of calcium for inducing cyclic AMP toxicity in target cells. Infect Immun (2002) 1.05
Anthrax toxin components stimulate chemotaxis of human polymorphonuclear neutrophils. Proc Soc Exp Biol Med (1985) 1.04
In vivo involvement of polymorphonuclear neutrophils in Leishmania infantum infection. BMC Microbiol (2001) 1.03
Dual role for macrophages in vivo in pathogenesis and control of murine Salmonella enterica var. Typhimurium infections. Eur J Immunol (2000) 1.01
A microtiter fluorometric assay to detect the germination of Bacillus anthracis spores and the germination inhibitory effects of antibodies. J Microbiol Methods (2004) 1.00
Liposome mediated affection of monocytes. Immunobiology (1992) 0.99
Bacillus species proteins involved in spore formation and degradation: from identification in the genome, to sequence analysis, and determination of function and structure. Crit Rev Biochem Mol Biol (2003) 0.90
Macrophage-dependent regulation of neutrophil mobilization and chemotaxis during development of sterile peritonitis in the rat. Eur J Haematol (2002) 0.88
Infiltration of neutrophils following injection of apoptotic cells into the peritoneal cavity. Apoptosis (2001) 0.84
Macrophages in spleen and liver direct the migration pattern of rat neutrophils during inflammation. Eur J Haematol (2004) 0.82
Mechanism of the inactivation of bacterial spores by reciprocal pressurization treatment. J Appl Microbiol (2003) 0.82
[The effect of lethal anthrax toxin on the functional activity of peritoneal mononuclear phagocytes and polymorphonuclear neutrophils in mice]. Zh Mikrobiol Epidemiol Immunobiol (1990) 0.82
Limited role of polymorphonuclear neutrophils in a pregnant mouse model of secondary infection by Chlamydophila abortus (Chlamydia psittaci serotype 1). Microb Pathog (2000) 0.80
Anthrax toxin induces hemolysis: an indirect effect through polymorphonuclear cells. J Infect Dis (2003) 0.80
Subpopulations of mouse blood monocytes differ in maturation stage and inflammatory response. J Immunol (2004) 8.65
Chitin induces accumulation in tissue of innate immune cells associated with allergy. Nature (2007) 5.82
NF-kappaB is a negative regulator of IL-1beta secretion as revealed by genetic and pharmacological inhibition of IKKbeta. Cell (2007) 4.56
Memory T(H)2 cells induce alternatively activated macrophages to mediate protection against nematode parasites. Nat Med (2006) 4.16
Control of TH17 cells occurs in the small intestine. Nature (2011) 4.03
Macrophage-derived Wnt opposes Notch signaling to specify hepatic progenitor cell fate in chronic liver disease. Nat Med (2012) 3.96
Inflammation-induced lymphangiogenesis in the cornea arises from CD11b-positive macrophages. J Clin Invest (2005) 3.77
Ly6c+ "inflammatory monocytes" are microglial precursors recruited in a pathogenic manner in West Nile virus encephalitis. J Exp Med (2008) 3.08
Mucosal damage and neutropenia are required for Candida albicans dissemination. PLoS Pathog (2008) 2.80
An essential role for TH2-type responses in limiting acute tissue damage during experimental helminth infection. Nat Med (2012) 2.60
Phagocyte-derived catecholamines enhance acute inflammatory injury. Nature (2007) 2.56
Protective influenza-specific CD8 T cell responses require interactions with dendritic cells in the lungs. J Exp Med (2008) 2.55
Alum induces innate immune responses through macrophage and mast cell sensors, but these sensors are not required for alum to act as an adjuvant for specific immunity. J Immunol (2009) 2.47
Monocyte chemoattractant protein-1 regulation of blood-brain barrier permeability. J Cereb Blood Flow Metab (2005) 2.45
Macrophages prevent human red blood cell reconstitution in immunodeficient mice. Blood (2011) 2.24
Mouse and human neutrophils induce anaphylaxis. J Clin Invest (2011) 2.21
The Ly-6Chigh monocyte subpopulation transports Listeria monocytogenes into the brain during systemic infection of mice. J Immunol (2004) 2.07
Macrophages and skeletal muscle regeneration: a clodronate-containing liposome depletion study. Am J Physiol Regul Integr Comp Physiol (2006) 1.94
Macrophages support pathological erythropoiesis in polycythemia vera and β-thalassemia. Nat Med (2013) 1.89
Lung interstitial macrophages alter dendritic cell functions to prevent airway allergy in mice. J Clin Invest (2009) 1.87
Universal vaccine based on ectodomain of matrix protein 2 of influenza A: Fc receptors and alveolar macrophages mediate protection. J Immunol (2010) 1.79
Respiratory syncytial virus-induced activation of nuclear factor-kappaB in the lung involves alveolar macrophages and toll-like receptor 4-dependent pathways. J Infect Dis (2002) 1.77
Adenovirus vector-induced innate inflammatory mediators, MAPK signaling, as well as adaptive immune responses are dependent upon both TLR2 and TLR9 in vivo. J Immunol (2008) 1.76
Osteal macrophages promote in vivo intramembranous bone healing in a mouse tibial injury model. J Bone Miner Res (2011) 1.76
WNT signaling drives cholangiocarcinoma growth and can be pharmacologically inhibited. J Clin Invest (2015) 1.68
Cutting edge: resistance to Bacillus anthracis infection mediated by a lethal toxin sensitive allele of Nalp1b/Nlrp1b. J Immunol (2009) 1.63
In vitro-derived alternatively activated macrophages reduce colonic inflammation in mice. Gastroenterology (2010) 1.61
Activated macrophages are essential in a murine model for T cell-mediated chronic psoriasiform skin inflammation. J Clin Invest (2006) 1.58
Lack of CD47 on nonhematopoietic cells induces split macrophage tolerance to CD47null cells. Proc Natl Acad Sci U S A (2007) 1.58
C5a initiates the inflammatory cascade in immune complex peritonitis. J Immunol (2004) 1.57
Role of T cells in innate and adaptive immunity against murine Burkholderia pseudomallei infection. J Infect Dis (2005) 1.56
The EGF/CSF-1 paracrine invasion loop can be triggered by heregulin beta1 and CXCL12. Cancer Res (2009) 1.56
Inescapable need for neutrophils as mediators of cellular innate immunity to acute Pseudomonas aeruginosa pneumonia. Infect Immun (2009) 1.52
IL-15 trans-presentation by pulmonary dendritic cells promotes effector CD8 T cell survival during influenza virus infection. J Exp Med (2010) 1.52
Macrophages mediate inflammation-enhanced metastasis of ovarian tumors in mice. Cancer Res (2007) 1.50
Type I IFNs enhance susceptibility to Chlamydia muridarum lung infection by enhancing apoptosis of local macrophages. J Immunol (2008) 1.49
Naïve CD8 T cell activation by liver bone marrow-derived cells leads to a "neglected" IL-2low Bimhigh phenotype, poor CTL function and cell death. J Hepatol (2012) 1.48
Mannose receptor expression specifically reveals perivascular macrophages in normal, injured, and diseased mouse brain. Glia (2005) 1.42
Influenza virus-like particles containing M2 induce broadly cross protective immunity. PLoS One (2011) 1.40
ICAM-1 triggers liver regeneration through leukocyte recruitment and Kupffer cell-dependent release of TNF-alpha/IL-6 in mice. Gastroenterology (2003) 1.37
The use of a model of in vivo macrophage depletion to study the role of macrophages during infection with Bacillus anthracis spores. Microb Pathog (2004) 1.34
Tissue macrophages suppress viral replication and prevent severe immunopathology in an interferon-I-dependent manner in mice. Hepatology (2010) 1.33
Extratumoral macrophages promote tumor and vascular growth in an orthotopic rat prostate tumor model. Neoplasia (2009) 1.33
Neutrophil depletion causes a fatal defect in murine pulmonary Staphylococcus aureus clearance. J Surg Res (2008) 1.30
Glycolipid presentation to natural killer T cells differs in an organ-dependent fashion. Proc Natl Acad Sci U S A (2005) 1.29
The mechanism of anti-CD20-mediated B cell depletion revealed by intravital imaging. J Clin Invest (2013) 1.27
Evasion by stealth: inefficient immune activation underlies poor T cell response and severe disease in SARS-CoV-infected mice. PLoS Pathog (2009) 1.24
Antiglioma immunological memory in response to conditional cytotoxic/immune-stimulatory gene therapy: humoral and cellular immunity lead to tumor regression. Clin Cancer Res (2009) 1.24
Vaccination inducing broad and improved cross protection against multiple subtypes of influenza A virus. Proc Natl Acad Sci U S A (2010) 1.22
Early activation of the alveolar macrophage is critical to the development of lung ischemia-reperfusion injury. J Thorac Cardiovasc Surg (2003) 1.22
A hemodynamic response to intravenous adenovirus vector particles is caused by systemic Kupffer cell-mediated activation of endothelial cells. Hum Gene Ther (2003) 1.22
Liver-stage development of Plasmodium falciparum, in a humanized mouse model. J Infect Dis (2006) 1.21
Modulation of macrophage activation state protects tissue from necrosis during critical limb ischemia in thrombospondin-1-deficient mice. PLoS One (2008) 1.21
Bacillus anthracis spores of the bclA mutant exhibit increased adherence to epithelial cells, fibroblasts, and endothelial cells but not to macrophages. Infect Immun (2007) 1.18
Stat3 activation in acute lung injury. J Immunol (2004) 1.18
Urokinase-type plasminogen activator plays essential roles in macrophage chemotaxis and skeletal muscle regeneration. J Immunol (2008) 1.17
CLEC-2 signaling via Syk in myeloid cells can regulate inflammatory responses. Eur J Immunol (2011) 1.16
Pertussis toxin targets airway macrophages to promote Bordetella pertussis infection of the respiratory tract. Infect Immun (2007) 1.15
Targeting tumor-associated macrophages in an orthotopic murine model of diffuse malignant mesothelioma. Mol Cancer Ther (2008) 1.14
Neutrophils transport antigen from the dermis to the bone marrow, initiating a source of memory CD8+ T cells. Immunity (2012) 1.14
Role of macrophages in early host resistance to respiratory Acinetobacter baumannii infection. PLoS One (2012) 1.12
The trans-sialidase from Trypanosoma cruzi induces thrombocytopenia during acute Chagas' disease by reducing the platelet sialic acid contents. Infect Immun (2005) 1.12
Therapeutic factor VIII levels and negligible toxicity in mouse and dog models of hemophilia A following gene therapy with high-capacity adenoviral vectors. Blood (2002) 1.11
Contrasting roles of macrophages and dendritic cells in controlling initial pulmonary Brucella infection. Eur J Immunol (2010) 1.11
Ulcerative colitis exacerbates lipopolysaccharide-induced damage to the nigral dopaminergic system: potential risk factor in Parkinson`s disease. J Neurochem (2010) 1.11
Prostaglandin E₂ signaling and bacterial infection recruit tumor-promoting macrophages to mouse gastric tumors. Gastroenterology (2010) 1.10
Early interactions between fully virulent Bacillus anthracis and macrophages that influence the balance between spore clearance and development of a lethal infection. Microbes Infect (2008) 1.10
Cell-type-specific type I interferon antagonism influences organ tropism of murine coronavirus. J Virol (2011) 1.07
Multiple helminth infection of the skin causes lymphocyte hypo-responsiveness mediated by Th2 conditioning of dermal myeloid cells. PLoS Pathog (2011) 1.07
MHC class I-specific antibody binding to nonhematopoietic cells drives complement activation to induce transfusion-related acute lung injury in mice. J Exp Med (2011) 1.06
The course of infections and pathology in immunomodulated NOD/LtSz-SCID mice inoculated with Plasmodium falciparum laboratory lines and clinical isolates. Int J Parasitol (2005) 1.05
Distinct immune effector pathways contribute to the full expression of peanut-induced anaphylactic reactions in mice. J Allergy Clin Immunol (2011) 1.05
The high-affinity human IgG receptor FcγRI (CD64) promotes IgG-mediated inflammation, anaphylaxis, and antitumor immunotherapy. Blood (2013) 1.03
Cutting Edge: The murine high-affinity IgG receptor FcγRIV is sufficient for autoantibody-induced arthritis. J Immunol (2011) 1.03
Technical advance: autofluorescence as a tool for myeloid cell analysis. J Leukoc Biol (2010) 1.02
Key aspects of the molecular and cellular basis of inhalational anthrax. Microbes Infect (2011) 1.02
c-FLIP maintains tissue homeostasis by preventing apoptosis and programmed necrosis. Sci Signal (2012) 1.01
Role of host cell traversal by the malaria sporozoite during liver infection. J Exp Med (2013) 1.01
Iron- and inflammation-induced hepcidin gene expression in mice is not mediated by Kupffer cells in vivo. Hepatology (2005) 1.01
Venezuelan equine encephalitis virus-vectored vaccines protect mice against anthrax spore challenge. Infect Immun (2003) 1.00
Roles of the Bacillus anthracis spore protein ExsK in exosporium maturation and germination. J Bacteriol (2009) 1.00
Enhanced erythropoiesis in Hfe-KO mice indicates a role for Hfe in the modulation of erythroid iron homeostasis. Blood (2010) 0.99
Contribution of TIR domain-containing adapter inducing IFN-beta-mediated IL-18 release to LPS-induced liver injury in mice. J Hepatol (2009) 0.99
Role of Rho GTPase in astrocyte morphology and migratory response during in vitro wound healing. J Neurochem (2005) 0.98
NK cells, but not NKT cells, are involved in Pseudomonas aeruginosa exotoxin A-induced hepatotoxicity in mice. J Immunol (2004) 0.98
Interferon-gamma-mediated tissue factor expression contributes to T-cell-mediated hepatitis through induction of hypercoagulation in mice. Hepatology (2013) 0.96
Fate of endothelialized modular constructs implanted in an omental pouch in nude rats. Tissue Eng Part A (2009) 0.96
Activator protein-1 activation in acute lung injury. Am J Pathol (2002) 0.95
Distinct macrophage subpopulations regulate viral encephalitis but not viral clearance in the CNS. J Neuroimmunol (2010) 0.94
Silica particles enhance peripheral thrombosis: key role of lung macrophage-neutrophil cross-talk. Am J Respir Crit Care Med (2005) 0.93
Cancer-induced expansion and activation of CD11b+ Gr-1+ cells predispose mice to adenoviral-triggered anaphylactoid-type reactions. Mol Ther (2009) 0.93
Chemokine receptor CCR2 is not essential for the development of experimental cerebral malaria. Infect Immun (2003) 0.93
CTLA4Ig inhibits effector T cells through regulatory T cells and TGF-β. J Immunol (2013) 0.92
Mouse adenovirus type 1 infection of macrophages. Virology (2009) 0.90
Systemic macrophage depletion inhibits Helicobacter bilis-induced proinflammatory cytokine-mediated typhlocolitis and impairs bacterial colonization dynamics in a BALB/c Rag2-/- mouse model of inflammatory bowel disease. Infect Immun (2012) 0.89
Macrophage-dependent regulation of neutrophil mobilization and chemotaxis during development of sterile peritonitis in the rat. Eur J Haematol (2002) 0.88
Induction of gp120-specific protective immune responses by genetic vaccination with linear polyethylenimine-plasmid complex. Vaccine (2005) 0.88